Sodium Citrate

枸橼酸钠

Report date: 2022/01/14 13:23:58
NME

Base Information

Drug NameSodium Citrate
Drug Alias NameE331Natrii citrasNatrii Citras DihydricusSodium, citrate deTrisodium Citrate +[11] 
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionUpdating
TargetsNot applicable
Therapy Area/IndicationsPost-Acute COVID-19 SyndromeAcidosisHeart Defects, Congenital +[7] 
Global Approved IndicationsAcidosis
Approved Indications in ChinaAcidosis
Original Approved Country/TerritoryJapan
Original Approved Date1955/03/01
Country/TerritoryBelgiumCanadaUnited States +[6] 
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesN/A
China Registration ClassN/A

Develop Information

Active CompaniesWarner LambertWrafton Laboratories LtdUniversity Of North Carolina At Chapel Hill +[5] 
Inactive CompaniesUniversitaire Ziekenhuizen LeuvenTexas Tech University Health Sciences Center El PasoVanderbilt University
Active IndicationsPost-Acute COVID-19 SyndromeAcidosisOlfaction Disorders
Inactive IndicationsHeart Defects, CongenitalRespiratory InsufficiencyLiver Failure +[4] 

Other Information

ATC CodeB05CB02
Related LinksWikipediaDrugBankKEGG